DRD1 and drug-induced dyskinesia: Even though D3R expression and D1R-D3R heteromers have been shown to increase in preclinical models of L-DOPA induced dyskinesia and to promote dyskinesia (Farré et al., 2015; Solis et al., 2017), further work is needed to characterize the potential implication of D1R-D3R heteromers in drug-evoked long-term adaptations.